MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

Clinical trial NCT01443065 · COMPLETED

Trial details

NCT number: NCT01443065
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Neoplasm of Esophagus Malignant Neoplasm of Stomach

Start date: 2011-01-01
Primary completion: 2014-03-01
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.